EFFECT OF SCREEN ADDICTION EDUCATION FOR PARENTS OF CHILDREN AGED 4-6 ON PROBLEMATIC MEDIA USE AND DIGITAL PARENTING SELF-EFFICACY
Condition(s) studied
Investigational drug(s) / intervention(s)
screen addiction training: The training program was prepared using specialized booklets and presentations, and in line with expert opinions.
Study summary
This study aims to examine the effect of screen addiction education given to parents of children aged 4-6 on children's problematic media use and parents digital parenting self-efficacy. The widespread use of digital technologies in early childhood has increased children's media habits and led to a risk of problematic screen use. It is known that parent knowledge and attitudes toward digital media directly influence children's media behaviors. Therefore, this study will evaluate the effectiveness of parental education in reducing children's problematic media use and improving parents digital parenting skills.
Eligibility
Primary outcome measure(s)
- Digital Parenting Self-Efficacy Scale — 6 weeks
Digital Parenting Self-Efficacy Scale, this scale was developed to assess parents' self-efficacy levels regarding media use. Items are scored on a Likert scale from 1 (not at all competent) to 5 (very competent). The scale consists of three sub-dimensions: digital literacy, digital safety, and digital communication. An increase in the score indicates a higher level of parental self-efficacy. - Problematic media use scale — 6 weeks
Problematic media use scale, the scale items are Likert-type, scored between 1 (never) and 5 (always). The total score obtained from the scale is divided by the number of items (27) to calculate the mean score. An increase in the obtained score indicates an increase in the level of problematic media use.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Zubeyde Hanim Kindergarten Gulbahar Hatun Kindergarten | Kahramanmaraş | Kahramanmaraş |
More Kahramanmaras Sutcu Imam University trials in Turkey
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07591545 on ClinicalTrials.gov ↗ ← All trials in Turkey